Global Facilities
Network

FAQs

• What CDMO services does AGC Biologics provide?

  AGC Biologics is a global Contract Development and Manufacturing Organization (CDMO) offering services from pre-clinical to commercial stages. We offer mammalian and microbial-based biologics, cell therapies, messenger RNA (mRNA), plasmid DNA (pDNA), viral vectors that support both cell and gene therapies, and support antibody-drug conjugates (ADCs). We partner with you from early clinical development work, through all phases of clinical trials and commercial-scale cGMP manufacturing. 
  
  

• Where are AGC Biologics' global manufacturing facilities located?

  We operate a global network of cGMP-compliant facilities across three continents. Our sites span U.S., Europe, and Asia with sites in Seattle (US), Copenhagen (Denmark), Heidelberg (Germany), Milan (Italy), Chiba (Japan), and Yokohama (Japan). This network allows us to serve as a local partner with global capabilities that can help you develop and produce your drug product as close as possible to the patient population you are wanting to reach. 

• Does AGC Biologics support technology transfer?

  Yes, we have specialized teams and protocols to facilitate seamless technology transfers of existing processes into our global network. We ensure process validation, gap analysis, and regulatory compliance at every stage to maintain product quality during the transfer.